Log in

Brain quinolinic acid in Alzheimer's dementia

  • Original Articles
  • Published:
European archives of psychiatry and neurological sciences Aims and scope Submit manuscript

Summary

Quinolinic acid (QA) content was measured in postmortem frontal and temporal cortex, putamen and cerebellum obtained from patients with senile dementia of Alzheimer type (SDAT), Huntington's disease (HD) and controls, using a gas chromatography/mass spectrometry method. There were no significant group differences in QA content of any of the regions examined. The data do not support the hypothesis that an accumulation of QA plays a role in neuronal degeneration occurring in the frontal and temporal cortex, putamen and cerebellum of patients with SDAT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ball MJ, Hachinski V, Fox A, Kirshen AJ, Fisman M, Blume W, Kral VA, Fox H (1985) A new definition of Alzheimer's disease: a hippocampal dementia. Lancet I:14–16

    Google Scholar 

  • Beal MF, Kowal NW, Ellison DW, Mazurek MF, Schwartz KJ, Martin JB (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature: 321:168–171

    Google Scholar 

  • Feldblum S, Rougier A, Loiseau H, Loiseau P, Cohadon F, Morselli PL, Lloyd KG (1988) Quinolinic-phosphoribosyltransferase activity is decreased in epileptic human brain tissue. Epilepsia 29:523–529

    Google Scholar 

  • Foster AC, Zinkand WC, Schwarcz R (1985) Quinolinic-acid phosphoribosyltransferase in rat brain. J Neurochem 44:446–454

    Google Scholar 

  • Foster AC, Zinkand WC, Schwarcz R (1986) Synthesis of quinolinic acid by 3-hydroxyantranilic acid oxygenase in rat brain tissue in vitro. J Neurochem 47:23–30

    Google Scholar 

  • Heyes MP, Garnett ES, Brown RR (1985) Normal excretion of quinolinic acid in Huntington's disease. Life Sci 37:1811–1816

    Google Scholar 

  • Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225:1168–1170

    Google Scholar 

  • Jellinger K, Riederer P (1984) Dementia in Parkinson's disease and (Pre)senile dementia of Alzheimer type: morphological aspect and changes in the intracerebral MAO activity. In: Hassler RG, Christ JF (eds) Advances in neurology, vol 40. Raven Press, New York, pp 199–210

    Google Scholar 

  • Khachaturian Zaven S (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42:1097–1105

    Google Scholar 

  • Moroni F, Lombardi G, Robitaille Y, Etienne P (1986a) Senile dementia and Alzheimer's disease: lack of changes of the cortical content of quinolinic acid. Neurobiol Aging 7:249–253

    Google Scholar 

  • Moroni F, Lombardi G, Carla V, Lal S, Etienne P, Nair NPV (1986b) Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure. J Neurochem 47:1667–1671

    Google Scholar 

  • Mountjoy CQ, Roth M, Evans NJR, Evans HM (1983) Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Aging 4:1–11

    Google Scholar 

  • Nieuwenhuys R, Voogd J, van Huijzen C (1981) The human central nervous system. A synopsis and atlas. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Reynolds GP, Pearson SJ, Halket J, Sandler M (1988) Brain quinolinic acid in Huntington's disease. J Neurochem 50:1959–1960

    Google Scholar 

  • Schwarcz R, Whetsell WO Jr, Mangano RM (1983) Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219:316–318

    Google Scholar 

  • Schwarcz R, Foster AC, French ED, Whetsell WO Jr, Köhler C (1984) Exitotoxic models for neurodegenerative disorders. Life Sci 35:19–32

    Google Scholar 

  • Schwarcz R, Okuno E, White RJ, Bird ED, Whetsell WO Jr (1988) 3-Hydroxyantranilate oxygenase activity is increased in the brains of Huntington disease victims. Proc Natl Acad Sci USA, Neurobiology 85:4079–4081

    Google Scholar 

  • Terry RD, Peck A, Deteresa R, Schechter R, Horoupian DS (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10:184–192

    Google Scholar 

  • Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, De Long MR (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237–1239

    Google Scholar 

  • Wolfensberger M, Amsler U, Cuenod M, Foster AC, Whetsell WO, Schwarcz R (1983) Identification of quinolinic acid in rat and human brain tissue. Neurosci Lett 41:247–252

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sofic, E., Halket, J., Przyborowska, A. et al. Brain quinolinic acid in Alzheimer's dementia. Eur Arch Psychiatr Neurol Sci 239, 177–179 (1989). https://doi.org/10.1007/BF01739651

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01739651

Key words

Navigation